STOCK TITAN

Acadia Pharmaceuticals to Present at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Acadia Pharmaceuticals (Nasdaq: ACAD) will participate in two upcoming virtual investor conferences. The BofA Securities 2021 Health Care Conference is on May 12, 2021, at 2:45 p.m. ET, followed by the RBC Capital Markets Global Healthcare Conference on May 18, 2021, at 3:05 p.m. ET. Live webcasts will be available on the company's website, with archived recordings accessible for about a month afterward. Acadia focuses on advancing neuroscience solutions for conditions like Parkinson's disease psychosis and dementia-related psychosis.

Positive
  • None.
Negative
  • None.

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate at the following investor conferences:

BofA Securities 2021 Health Care Conference
Fireside Chat Presentation: Wednesday, May 12, 2021 at 2:45 p.m. Eastern Time

RBC Capital Markets Global Healthcare Conference
Fireside Chat Presentation: Tuesday, May 18, 2021 at 3:05 p.m. Eastern Time

These conferences will be held virtually. Live webcasts of the presentations will be accessible on the company’s website, www.acadia-pharm.com, under the investors section and an archived recording will be available on the website for approximately one month following each presentation.

About Acadia Pharmaceuticals

Acadia is trailblazing breakthroughs in neuroscience to elevate life. For more than 25 years we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We developed and commercialized the first and only approved therapy for hallucinations and delusions associated with Parkinson’s disease psychosis. Our late-stage development efforts are focused on dementia-related psychosis, negative symptoms of schizophrenia and Rett syndrome, and in early-stage clinical research we are exploring novel approaches to pain management, and cognition and neuropsychiatric symptoms in central nervous system disorders. For more information, visit us at www.acadia-pharm.com and follow us on LinkedIn.

FAQ

What are the dates and times of Acadia Pharmaceuticals' upcoming conferences?

Acadia Pharmaceuticals will present at the BofA Securities 2021 Health Care Conference on May 12, 2021, at 2:45 p.m. ET, and at the RBC Capital Markets Global Healthcare Conference on May 18, 2021, at 3:05 p.m. ET.

Where can I watch the Acadia Pharmaceuticals conference presentations?

The presentations by Acadia Pharmaceuticals will be available via live webcasts on their website, with recordings archived for one month following each event.

What is Acadia Pharmaceuticals known for?

Acadia Pharmaceuticals is known for developing the first approved therapy for hallucinations and delusions associated with Parkinson’s disease psychosis and is involved in research for other central nervous system disorders.

What is Acadia Pharmaceuticals' stock symbol?

Acadia Pharmaceuticals' stock symbol is ACAD, listed on Nasdaq.

Which healthcare topics will Acadia Pharmaceuticals discuss at the conferences?

Acadia Pharmaceuticals will discuss advancements in neuroscience, particularly focusing on conditions such as dementia-related psychosis and negative symptoms of schizophrenia.

Acadia Pharmaceuticals Inc.

NASDAQ:ACAD

ACAD Rankings

ACAD Latest News

ACAD Stock Data

2.69B
164.23M
0.55%
97.1%
5.73%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
SAN DIEGO